These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6128589)

  • 21. Prolonged bradycardia after neostigmine administration in a patient taking nadolol.
    Seidl DC; Martin DE
    Anesth Analg; 1984 Mar; 63(3):365-7. PubMed ID: 6703355
    [No Abstract]   [Full Text] [Related]  

  • 22. [Evaluation of hypotensive effect of nadolol].
    Cybulska I; Brym E; Czerniewska E; Wołyńczyk-Niegowska J
    Pol Arch Med Wewn; 1980 Dec; 64(6):475-80. PubMed ID: 6111065
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of trazodone and nadolol upon human sperm motility.
    Cassidy SL; Pearson RM
    Br J Clin Pharmacol; 1986 Jul; 22(1):119-21. PubMed ID: 3741721
    [No Abstract]   [Full Text] [Related]  

  • 24. Redistribution of cardiac output to the kidneys during oral nadolol administration.
    Textor SC; Fouad FM; Bravo EL; Tarazi RC; Vidt DG; Gifford RW
    N Engl J Med; 1982 Sep; 307(10):601-5. PubMed ID: 7110207
    [No Abstract]   [Full Text] [Related]  

  • 25. Near-fatal bronchospasm after oral nadolol in a young asthmatic and response to ventilation with halothane.
    Raine JM; Palazzo MG; Kerr JH; Sleight P
    Br Med J (Clin Res Ed); 1981 Feb; 282(6263):548-9. PubMed ID: 6109556
    [No Abstract]   [Full Text] [Related]  

  • 26. The antihypertensive effects of doxazosin: a clinical overview.
    Cox DA; Leader JP; Milson JA; Singleton W
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):83S-90S. PubMed ID: 2939872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydrochlorothiazide and nadolol in the treatment of hypertension.
    Olerud B
    Practitioner; 1982 Apr; 226(1366):785-7. PubMed ID: 7045854
    [No Abstract]   [Full Text] [Related]  

  • 28. Severe chronic diarrhea secondary to celiprolol.
    Machet L; Codjovi P; Jonville AP; Autret E
    Ann Pharmacother; 1992 Jun; 26(6):842-3. PubMed ID: 1351767
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of nadolol, a new long-acting beta-receptor blocking agent, and placebo in the treatment of stable angina pectoris.
    Shapiro W; Park J; DiBianco R; Singh SN; Katz RJ; Fletcher R
    Chest; 1981 Oct; 80(4):425-30. PubMed ID: 6791883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A report on the clinical efficacy of nadolol--a new long acting beta-blocker.
    Hill LS; Fand RS
    Ir Med J; 1979 Dec; 72(12):522-9. PubMed ID: 44273
    [No Abstract]   [Full Text] [Related]  

  • 31. Nadolol (Corgard) - a new beta-blocker.
    Med Lett Drugs Ther; 1980 Apr; 22(8):33-4. PubMed ID: 6102734
    [No Abstract]   [Full Text] [Related]  

  • 32. Nadolol: a new beta-adrenoceptor antagonist.
    Frishman WH
    N Engl J Med; 1981 Sep; 305(12):678-82. PubMed ID: 6115316
    [No Abstract]   [Full Text] [Related]  

  • 33. [Nadolol, a long-term acting beta blocking agent, in the treatment of essential arterial hypertension].
    Semplicini A; Pessina AC; Rossi GP; Tagliafierro R; Lusiani L; Castellani V; Bedogni F; Mazzucato A; Ronsisvalle G
    Cardiologia; 1982 Sep; 27(9):853-64. PubMed ID: 6765278
    [No Abstract]   [Full Text] [Related]  

  • 34. [Beta-blockers and arterial hypertension: comparison between nadolol and propranolol].
    Abate G; Polimeni RM; Di Peppe MC; Guarino F; Troja C; Marisi F; Cerritelli E; Brillante C; De Angelis M
    Clin Ter; 1982 Aug; 102(3):283-291. PubMed ID: 7140182
    [No Abstract]   [Full Text] [Related]  

  • 35. Controlled trial on three beta-blockers: antihypertensive efficacy and effect on the hypertensive heart disease.
    Pupita F; Ansuini R; Belogi M; Pupita G; Gaggi S
    Int J Clin Pharmacol Res; 1985; 5(6):439-45. PubMed ID: 2869001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postural hypotension in elderly patients given carvedilol.
    Krum H; Conway EL; Broadbear JH; Howes LG; Louis WJ
    BMJ; 1994 Sep; 309(6957):775-6. PubMed ID: 7950564
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of chronic treatment with a non-selective beta-adrenoceptor antagonist on the enteroinsular axis and intermediary metabolites.
    Peden NR; Dow RJ; Isles TE; Martin BT; Yee KF; Buchanan KD
    Diabetes Res; 1985 May; 2(3):135-9. PubMed ID: 3905182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diacetyl nadolol: 3-month ocular hypotensive effect in glaucomatous eyes.
    Duzman E; Rosen N; Lazar M
    Br J Ophthalmol; 1983 Oct; 67(10):668-73. PubMed ID: 6137236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurotoxicity related to the use of topical tretinoin (Retin-A).
    Bernstein AL; Leventhal-Rochon JL
    Ann Intern Med; 1996 Jan; 124(2):227-8. PubMed ID: 8533998
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term treatment of essential hypertension with Nadolol and Hydrochlorothiazide: a two-year follow-up.
    El-Mehairy MM; Shaker A; Ramadan M; Hamza S; Tadros SS
    J Int Med Res; 1982; 10(2):87-91. PubMed ID: 6802691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.